Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 21

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 21
---
 | the historical trading price and trading volume of our common stock;                                                                                                                                                                                                                         |
| · | the then-prevailing trading price and trading volume of our common stock and the expected impact of the Reverse Stock Split on the trading market for our common stock in the short- and long-term;                                                                                          |
| · | our ability to maintain our listing on The Nasdaq Capital Market;                                                                                                                                                                                                                            |
| · | which Reverse Stock Split ratio would result in the least administrative cost to us;                                                                                                                                                                                                         |
| · | prevailing general market and economic conditions; and                                                                                                                                                                                                                                       |
| · | if our stockholders approve this Proposal 1, the additional authorized but unissued shares of common stock that will result from the implementation of a Reverse Stock Split, which will be available to provide flexibility to use our common stock for business and/or financial purposes. |

| 11 |

Certain Risks and Potential Disadvantages Associated with Reverse Stock Split

We cannot assure you that the proposed Reverse Stock Split will increase our stock price and have the desired effect of maintaining compliance with Nasdaq Marketplace Rules. We
expect that the Reverse Stock Split will increase the market price of our common stock so that we may be able to regain and maintain compliance
with the Nasdaq $1.00 minimum bid price requirement. However, the effect of the Reverse Stock Split upon the market price of our common
stock cannot be predicted with any certainty, and the history of similar reverse stock splits for companies in like circumstances is varied,
particularly since some investors may view a reverse stock split negatively. It is possible that the per share price of our common stock
after the Reverse Stock Split will not rise in proportion to the reduction in the number of shares of our common stock outstanding resulting
from the Reverse Stock Split, and the market price per post-Reverse Stock Split share may not exceed or remain in excess of the $1.00
minimum bid price for a sustained period of time, and the Reverse Stock Split may not result in a per share price that would attract brokers
and investors who do not trade in lower priced stocks. In addition, although we believe the Reverse Stock Split may enhance the desirability
of our common stock to certain potential investors, it is possible that, if implemented, our common stock may not become more attractive
to institutional and other long term investors. Even if we implement the Reverse Stock Split, the market price of our common stock may
decrease due to factors unrelated to the Reverse Stock Split. In any case, the market price of our common